{"transactions":[{"id":809559,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2026-04-13T20:41:29.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person earned 32,000 shares upon the satisfaction of the performance condition of certain performance stock units granted to the Reporting Person on February 26, 2025. The performance conditions were deemed to have been 40% achieved on March 4, 2026. One-third of these stock units vested as of March 4, 2026, one-third will vest on January 1, 2027 and one-third will vest on January 1, 2028, subject to the Reporting Person's continued service."}],"balance_after":1340231,"source":{"system":"sec-edgar","filing":"0001326765-26-000004","document":"form4a-04132026_080425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000132676526000004/form4a-04132026_080425.xml","form_type":"4/A","original_submission_date":"2026-03-05"}},{"id":858045,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T21:32:51.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the option vests on February 17, 2027 and fifty percent (50%) of the option vests on February 17, 2028, so long as the Reporting Person continues to provide services through such vesting dates."}],"balance_after":500000,"derivative":{"exercise_price":0.156,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001326765-26-000003","document":"form4-03052026_090348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000132676526000003/form4-03052026_090348.xml","form_type":"4"}},{"id":935127,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2026-01-20T21:03:15.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":0.1994,"value":2392.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.1993 to $0.2001. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1308231,"source":{"system":"sec-edgar","filing":"0001326765-26-000002","document":"form4-01202026_090111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000132676526000002/form4-01202026_090111.xml","form_type":"4"}},{"id":958029,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2025-12-29T23:04:48.000Z","date":"2025-12-26","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":0.2096,"value":8384.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.2088 to $0.213. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1320231,"source":{"system":"sec-edgar","filing":"0001326765-25-000007","document":"form4-12292025_111245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000132676525000007/form4-12292025_111245.xml","form_type":"4"}},{"id":1007932,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2025-11-05T01:46:59.000Z","date":"2025-11-03","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":0.55,"value":82500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.5450 to $0.5785. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1360231,"source":{"system":"sec-edgar","filing":"0001326765-25-000006","document":"form4-11052025_011154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000132676525000006/form4-11052025_011154.xml","form_type":"4"}},{"id":1217037,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2025-03-07T21:05:07.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":9725,"price":0.8579,"value":8343.0775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.8575 to $0.8588. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1510231,"source":{"system":"sec-edgar","filing":"0001415889-25-007367","document":"form4-03072025_040303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000141588925007367/form4-03072025_040303.xml","form_type":"4"}},{"id":1238094,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2025-02-28T21:05:08.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":80368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person earned 80,368 shares upon the satisfaction of the performance condition of certain performance stock units granted to the Reporting Person on December 26, 2023. One-third of these stock units vested as of February 26, 2025, one-third will vest on January 1, 2026 and one-third will vest on January 1, 2027, subject to the Reporting Person's continued service."}],"balance_after":1519956,"source":{"system":"sec-edgar","filing":"0001415889-25-005989","document":"form4-02282025_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000141588925005989/form4-02282025_040203.xml","form_type":"4"}},{"id":1319690,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2024-12-31T21:15:11.000Z","date":"2024-12-27","kind":"sale","planned":true,"acquired":false,"shares":24500,"price":1.0249,"value":25110.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person (pursuant to a 10b5-1 Plan dated September 13, 2024) to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $1.015 to $1.035. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1439588,"source":{"system":"sec-edgar","filing":"0001415889-24-030315","document":"form4-12312024_041207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000141588924030315/form4-12312024_041207.xml","form_type":"4"}},{"id":1319689,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and COO"}}],"security":"Common Stock","published_at":"2024-12-31T21:15:11.000Z","date":"2024-12-23","kind":"grant","planned":true,"acquired":true,"shares":241000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of December 23, 2024, provided that Reporting Person continues to provide services to the Company through each vesting date."}],"balance_after":1464088,"source":{"system":"sec-edgar","filing":"0001415889-24-030315","document":"form4-12312024_041207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000141588924030315/form4-12312024_041207.xml","form_type":"4"}},{"id":1374045,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-06T23:52:48.000Z","date":"2024-11-04","kind":"sale","planned":false,"acquired":false,"shares":120000,"price":1.3155,"value":157860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $1.29 to $1.35. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1223088,"source":{"system":"sec-edgar","filing":"0001415889-24-026277","document":"form4-11062024_111144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000141588924026277/form4-11062024_111144.xml","form_type":"4"}},{"id":1698471,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-28T21:21:08.000Z","date":"2023-12-26","kind":"grant","planned":false,"acquired":true,"shares":241105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of December 26, 2023, provided that Reporting Person continues to provide services to the Company through each vesting date."}],"balance_after":1343088,"source":{"system":"sec-edgar","filing":"0001209191-23-059899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000120919123059899/doc4.xml","form_type":"4"}},{"id":1752384,"issuer":{"id":52695,"kind":"organization","name":"Origin Materials, Inc.","symbol":"ORGN"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-01T20:47:08.000Z","date":"2023-10-30","kind":"grant","planned":false,"acquired":true,"shares":1101983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of October 30, 2023, provided that Reporting Person continues to provide services to the Company through each vesting date."}],"balance_after":1101983,"source":{"system":"sec-edgar","filing":"0001209191-23-054030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326765/000120919123054030/doc4.xml","form_type":"4"}},{"id":2897637,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-25T23:51:36.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service."}],"balance_after":435450,"derivative":{"exercise_price":3.05,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-21-005219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121005219/doc4.xml","form_type":"4"}},{"id":2897636,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-25T23:51:36.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":585,"price":3.16,"value":1848.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 585 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":14285,"source":{"system":"sec-edgar","filing":"0001209191-21-005219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121005219/doc4.xml","form_type":"4"}},{"id":3291589,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T21:11:21.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024."}],"balance_after":185450,"derivative":{"exercise_price":4.91,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001209191-20-006282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006282/doc4.xml","form_type":"4"}},{"id":3291588,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-04T21:11:21.000Z","date":"2020-02-03","kind":"purchase","acquired":true,"shares":700,"price":1.72,"value":1204.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":13700,"source":{"system":"sec-edgar","filing":"0001209191-20-006282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006282/doc4.xml","form_type":"4"}},{"id":3368161,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2019-11-18T18:32:26.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":1000,"price":4.0795,"value":4079.5,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-19-056884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119056884/doc4.xml","form_type":"4"}},{"id":3407822,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-23T23:18:40.000Z","date":"2019-09-23","kind":"purchase","acquired":true,"shares":2000,"price":5.25,"value":10500.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-19-050493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119050493/doc4.xml","form_type":"4"}},{"id":3418511,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-10T22:24:24.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":1000,"price":6.5205,"value":6520.5,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-049077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/doc4.xml","form_type":"4"}},{"id":3418510,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-10T22:24:24.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":1000,"price":6.493,"value":6493.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-19-049077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/doc4.xml","form_type":"4"}},{"id":3427349,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-28","kind":"purchase","acquired":true,"shares":1000,"price":6.88,"value":6880.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427348,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":2000,"price":8.93,"value":17860.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427347,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":1000,"price":8.95,"value":8950.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427346,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":1000,"price":9.3,"value":9300.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427345,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":1000,"price":9.32,"value":9320.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427344,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-26","kind":"purchase","acquired":true,"shares":1000,"price":9.22,"value":9220.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427343,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-26","kind":"purchase","acquired":true,"shares":1000,"price":8.33,"value":8330.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427322,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":1000,"price":6.88,"value":6880.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427321,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":2000,"price":8.93,"value":17860.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427320,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":1000,"price":8.95,"value":8950.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427319,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":1000,"price":9.3,"value":9300.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427318,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":1000,"price":9.32,"value":9320.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427317,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":1000,"price":9.22,"value":9220.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427316,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":1000,"price":8.33,"value":8330.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3497126,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T20:00:48.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or June 3, 2020, with the remaining 75% vesting in 36 equal installments beginning June 30, 2020 and ending May 31, 2023, subject to the Participant's continued service."}],"balance_after":109450,"derivative":{"exercise_price":5.04,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-19-035500","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119035500/doc4.xml","form_type":"4"}},{"id":3810634,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-20T23:24:04.000Z","date":"2018-09-18","kind":"grant","acquired":true,"shares":47200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest monthly in equal installments over a period of two years from the date of the grant, subject to the Participant's continued service."}],"balance_after":83450,"derivative":{"exercise_price":4.63,"exercise_date":"2018-10-30","expiration_date":"2028-09-18","underlying":"Common Stock","underlying_shares":47200},"source":{"system":"sec-edgar","filing":"0001209191-18-051840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919118051840/doc4.xml","form_type":"4"}},{"id":4286981,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T22:07:23.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service."}],"balance_after":225000,"derivative":{"exercise_price":0.7,"exercise_date":"2018-06-08","expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-17-038975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919117038975/doc4.xml","form_type":"4"}},{"id":4605794,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-12T21:29:35.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months."}],"balance_after":37500,"derivative":{"exercise_price":15,"expiration_date":"2026-09-11","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-16-140964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919116140964/doc4.xml","form_type":"4"}},{"id":4605793,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-12T21:29:35.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months."}],"balance_after":37500,"derivative":{"exercise_price":12,"expiration_date":"2026-09-11","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-16-140964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919116140964/doc4.xml","form_type":"4"}},{"id":4605792,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-12T21:29:35.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months."}],"balance_after":150000,"derivative":{"exercise_price":8,"expiration_date":"2026-09-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-16-140964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919116140964/doc4.xml","form_type":"4"}},{"id":4605791,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-12T21:29:35.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months."}],"balance_after":150000,"derivative":{"exercise_price":6,"expiration_date":"2026-09-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-16-140964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919116140964/doc4.xml","form_type":"4"}},{"id":4605790,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-12T21:29:35.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months."}],"balance_after":125000,"derivative":{"exercise_price":2.17,"expiration_date":"2026-09-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-16-140964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919116140964/doc4.xml","form_type":"4"}}]}